{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:36:45Z","timestamp":1762101405271},"reference-count":20,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":11534,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1981,8,9]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> One hundred twenty patients about to receive their first treatment with potentially nauseant cancer chemotherapy were randomized to one of six antiemetic treatments: (1) no treatment; (2) placebo; (3) prochlorperazine (PCPZ), 10 mg; (4) \u0394<jats:sup>9<\/jats:sup>\u2010tetrahydrocannabinol (THC), 5 mg; (5) THC, 10 mg; (6) THC, 15 mg. Four doses of each medication were given orally at 4\u2010hour intervals starting 2 hours before chemotherapy. A study nurse was responsible for both objective (nurse) and subjective (patient) symptom questionnaires. Serum levels were obtained at intervals for cross\u2010reacting cannabinoids. Physiologic measurements including intraocular pressure (IOP), blood pressure, and pulmonary function were also recorded. In summary, the patients were remarkably free of adverse physiologic effects. All intraocular pressures before and after treatment were within the normal range, although a surprising stastistically significant increase in IOP occurred in the group receiving 5 mg THC.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1981.tb02583.x","type":"journal-article","created":{"date-parts":[[2013,3,9]],"date-time":"2013-03-09T01:35:12Z","timestamp":1362792912000},"source":"Crossref","is-referenced-by-count":12,"title":["Physiologic Observations in a Controlled Clinical Trial of the Antiemetic Effectiveness of 5, 10, and 15 mg of \u0394<sup>9<\/sup>\u2010Tetrahydrocannabinol in Cancer Chemotherapy. Ophthalmologic Implications"],"prefix":"10.1002","volume":"21","author":[{"given":"M.","family":"LEVITT","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"WILSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"BOWMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"KEMEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"KREPART","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"MARKS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"SCHIPPER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"THOMSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"WEINERMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"WEINERMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-89-4-539"},{"key":"e_1_2_1_3_2","first-page":"420","article-title":"Acute effects of smoked marijuana and oral delta\u20109\u2010tetrahydrocannabinol on specific airway conductance in asthmatic subjects","volume":"109","author":"Tashkin DP","year":"1974","journal-title":"Am Rev Resp Dis."},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.31.6.720"},{"key":"e_1_2_1_5_2","first-page":"305","article-title":"Chronic inhalation of marijuana and tobacco in dogs: pulmonary pathology","volume":"14","author":"Roy PE","year":"1976","journal-title":"Res Commun Chem Pathol Pharmacol."},{"key":"e_1_2_1_6_2","first-page":"50","volume-title":"Testimony in Marijuana\u2010Hashish Epidemic and Its Impact on United States Security.","author":"Heath RG","year":"1975"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/242403a0"},{"key":"e_1_2_1_8_2","first-page":"111","article-title":"Alveolar macrophages: structural and functional differences between nonsmokers and smokers of marijuana and tobacco","volume":"25","author":"Mann PEG","year":"1971","journal-title":"Lab Invest."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1971125762"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197208032870501"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197407112910203"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197906073002302"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.72.1.20"},{"key":"e_1_2_1_14_2","first-page":"441","article-title":"Cardiopulmonary effects of marihuana smoking during exercise","volume":"70","author":"Shapiro BJ","year":"1976","journal-title":"Chest."},{"key":"e_1_2_1_15_2","volume-title":"Marijuana: Chemistry, Biochemistry, and Cellular Effects.","author":"Marks V","year":"1976"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","DOI":"10.1097\/00006324-197709000-00019","volume-title":"Glaucoma Guidebook.","author":"Portney GL","year":"1977"},{"key":"e_1_2_1_17_2","first-page":"921","article-title":"Delta\u20109\u2010tetrahydrocannabinol; euphoria and intraocular pressure in man","volume":"7","author":"Purnell WD","year":"1975","journal-title":"Ann Ophthalmol."},{"key":"e_1_2_1_18_2","first-page":"63","volume-title":"The Therapeutic Potential of Marijuana.","author":"Hepler RS","year":"1975"},{"key":"e_1_2_1_19_2","unstructured":"MerrittJCPersonal communication."},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1981.tb02601.x"},{"key":"e_1_2_1_21_2","unstructured":"SuranA.Personal communication."}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1981.tb02583.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1981.tb02583.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T05:46:02Z","timestamp":1694583962000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1981.tb02583.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,8,9]]},"references-count":20,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1981,8,9]]}},"alternative-id":["10.1002\/j.1552-4604.1981.tb02583.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1981.tb02583.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,8,9]]}}}